Towards multi-target antidiabetic agents: Discovery of biphenyl-benzimidazole conjugates as AMPK activators

DA Babkov, ON Zhukowskaya, AV Borisov… - Bioorganic & medicinal …, 2019 - Elsevier
Type 2 diabetes mellitus is a complex metabolic disorder requiring polypharmacology
approaches for effective treatment. Combinatorial library of fifteen new tricyclic …
被引用次数：45 相关文章

Towards multi-target antidiabetic agents: Discovery of biphenyl-benzimidazole conjugates as AMPK activators

DA Babkov, ON Zhukowskaya… - Bioorganic & …, 2019 - pubmed.ncbi.nlm.nih.gov
Type 2 diabetes mellitus is a complex metabolic disorder requiring polypharmacology
approaches for effective treatment. Combinatorial library of fifteen new tricyclic …

Towards multi-target antidiabetic agents: Discovery of biphenyl-benzimidazole conjugates as AMPK activators.

DA Babkov, ON Zhukowskaya, AV Borisov… - Bioorganic & …, 2019 - europepmc.org
Type 2 diabetes mellitus is a complex metabolic disorder requiring polypharmacology
approaches for effective treatment. Combinatorial library of fifteen new tricyclic …

Towards multi-target antidiabetic agents: Discovery of biphenyl-benzimidazole conjugates as AMPK activators

DA Babkov, ON Zhukowskaya, AV Borisov… - … & Medicinal Chemistry …, 2019 - hero.epa.gov
Type 2 diabetes mellitus is a complex metabolic disorder requiring polypharmacology
approaches for effective treatment. Combinatorial library of fifteen new tricyclic …

Towards multi-target antidiabetic agents: Discovery of biphenyl-benzimidazole conjugates as AMPK activators

D Babkov, O Zhukowskaya, AV Borisov… - Bioorganic & Medicinal …, 2019 - elibrary.ru
Type 2 diabetes mellitus is a complex metabolic disorder requiring polypharmacology
approaches for effective treatment. Combinatorial library of fifteen new tricyclic …